A novel, disruptive vaccination technology: Self-adjuvanted RNActive ® vaccines

Kallen, Karl-Josef, Heidenreich, Regina, Schnee, Margit, Petsch, Benjamin, Schlake, Thomas, Thess, Andreas, Baumhof, Patrick, Scheel, Birgit +2 more·2013·Human Vaccines & Immunotherapeutics

Cited by (223)

Items 101–200 of 223

  1. Rational design of protamine nanocapsules as antigen delivery carriers
    José Vicente González-Aramúndiz, Elena Presas, Inmaculada Dalmau‐Mena, Susana Martínez-Pulgarín, Covadonga Alonso, José M. Escribano, Marı́a José Alonso, Nœmi Csaba · 2016 · Journal of Controlled Release
  2. mRNA vaccines in the prevention and treatment of diseases
    Yangzhuo Gu, Jiangyao Duan, Na Yang, Yuxin Yang, Xing Zhao · 2022 · MedComm
  3. A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
    Annett Ziegler, Claudia Soldner, Stefan Lienenklaus, Julia Spanier, Stephanie Trittel, Peggy Riese, Thomas Kramps, Siegfried Weiß, Regina Heidenreich, Edith Jasny et al. · 2017 · The Journal of Immunology
  4. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer
    Rama Rao Malla, Mundla Srilatha, Batoul Farran, Ganji Purnachandra Nagaraju · 2023 · Molecular Therapy
  5. Advances in the design and delivery of RNA vaccines for infectious diseases
    Abhijeet Girish Lokras, Thomas Rønnemoes Bobak, Saahil Sandeep Baghel, Federica Sebastiani, Camilla Foged · 2024 · Advanced Drug Delivery Reviews
  6. mRNA delivery in cancer immunotherapy
    Yichen Zhong, Shi Du, Yizhou Dong · 2023 · Acta Pharmaceutica Sinica B
  7. Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations
    Xiujuan Jia, Yong Liu, Angela M. Wagner, Michelle M. Chen, Yuejie Zhao, Katelyn J. Smith, Dan Some, Andreas M. Abend, Justin P. Pennington · 2021 · Journal of Chromatography B
  8. Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives
    Yunchao Zhang, Chenxin Liu, Chunjie Wu, Linjiang Song · 2023 · Biomedicine & Pharmacotherapy
  9. Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art
    Luke H. Rhym, Daniel G. Anderson · 2022 · Med
  10. Regulatory Considerations on the Development of mRNA Vaccines
    Ramachandra Naik, Keith Peden · 2020 · Current topics in microbiology and immunology
  11. Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution
    Emma Rey-Jurado, Felipe Tapia, Natalia Muñoz‐Durango, Margarita K. Lay, Leandro J. Carreño, Claudia A. Riedel, Susan M. Bueno, Yvonne Genzel, Alexis M. Kalergis · 2018 · Frontiers in Immunology
  12. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
    Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, Labiba Mustabina Oishee, Mutia Masuka Muna · 2022 · RNA Biology
  13. Influenza Viruses: Innate Immunity and mRNA Vaccines
    SangJoon Lee, Jin‐Hyeob Ryu · 2021 · Frontiers in Immunology
  14. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
    Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, Seyedeh Habibeh Mirmajidi, Iman Zare, Yasaman Naeimzadeh, Atena Mansouri, Amir Tajbakhsh, Amir Savardashtaki, Amirhossein Sahebkar · 2024 · Journal of Nanobiotechnology
  15. Stimuli-responsive nanomaterials for the precision delivery of mRNA cancer vaccines
    Ruby Srivastava · 2025 · Nano Trends
  16. Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines
    Saed Abbasi, Satoshi Uchida · 2021 · Pharmaceutics
  17. Broadly protective influenza vaccines: design and production platforms
    Husni Elbahesh, Giulietta Saletti, Thomas H. Gerlach, Guus F. Rimmelzwaan · 2018 · Current Opinion in Virology
  18. Path towards mRNA delivery for cancer immunotherapy from bench to bedside
    Wenfei Chen, Yining Zhu, Jinhan He, Xun Sun · 2023 · Theranostics
  19. Opportunities for innovation: Building on the success of lipid nanoparticle vaccines
    Jessica Y. Huang, Daniel Yuen, Justine D. Mintern, Angus P. R. Johnston · 2021 · Current Opinion in Colloid & Interface Science
  20. mRNA vaccines: A novel weapon to control infectious diseases
    Yuying Tian, Zhuoya Deng, Penghui Yang · 2022 · Frontiers in Microbiology
  21. What is the relationship between sociotechnical transition and disruptive innovations?
    Yorgos Marinakis, Steven T. Walsh, Reilly White · 2023 · Technological Forecasting and Social Change
  22. Advances in mRNA vaccines
    Mengyun Li, Zining Wang, Chunyuan Xie, Xiaojun Xia · 2022 · International review of cytology
  23. Protamine-Controlled Reversible DNA Packaging: A Molecular Glue
    Arnab Mukherjee, Ambroise de Izarra, Jéril Degrouard, E Olive, Prabal Kumar Maiti, Yun Hee Jang, Yves Lansac · 2021 · ACS Nano
  24. Application of mRNA Technology in Cancer Therapeutics
    Yeşim Eralp · 2022 · Vaccines
  25. Engineered Nanoparticle Applications for Recombinant Influenza Vaccines
    Zachary R. Sia, Matthew S. Miller, Jonathan F. Lovell · 2020 · Molecular Pharmaceutics
  26. Vaccine Design and Vaccination Strategies against Rickettsiae
    Anke Osterloh · 2021 · Vaccines
  27. Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases
    Yihan Lu, Ciying Qian, Yang Huang, Tianyu Ren, Wuzhi Xie, Ningshao Xia, Shaowei Li · 2025 · International Journal of Biological Macromolecules
  28. Nucleic acid vaccination strategies against infectious diseases
    Małgorzata Anna Marć, Enrique Domínguez‐Álvarez, Carlos Gamazo · 2015 · Expert Opinion on Drug Delivery
  29. Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs
    Kirill Vasilyev, Anna-Polina S. Shurygina, Maria V. Sergeeva, Marina Stukova, Andrej Egorov · 2021 · Microorganisms
  30. Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: A systematic review and meta-analysis of vaccine clinical trials
    Brijesh Sathian, Mohammad Asim, Indrajit Banerjee, Bedanta Roy, Ana Beatriz Pizarro, Maraeh Angela Mancha, Edwin van Teijlingen, Hamed Kord‐Varkaneh, Ahammed Abdulla Mekkodathil, Supram Hosuru Subramanya et al. · 2021 · Nepal Journal of Epidemiology
  31. Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
    Lei‐Ming Cao, Yi-Fu Yu, Zi‐Zhan Li, Nian‐Nian Zhong, Guang-Rui Wang, Yao Xiao, Bing Liu, Qiuji Wu, Chun Feng, Lin‐Lin Bu · 2024 · Journal of Nanobiotechnology
  32. Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines
    Cristina Manara, Michela Brazzoli, Diego Piccioli, Marianna Taccone, Ugo D’Oro, Domenico Maione, Elisabetta Frigimelica · 2019 · Vaccine
  33. Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems
    Sarah S. Nasr, Sangeun Lee, Durairaj Thiyagarajan, Annette S. Boese, Brigitta Loretz, Claus‐Michael Lehr · 2021 · Pharmaceutics
  34. Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
    Cong Liu, Dimitri Papukashvili, Yu Dong, Xingyun Wang, Xing Hu, Nuo Yang, Jie Cai, Fengfei Xie, Nino Rcheulishvili, Peng George Wang · 2022 · Frontiers in Cell and Developmental Biology
  35. mRNA delivery technologies: Toward clinical translation
    Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís · 2022 · International review of cytology
  36. Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment
    Fabiola Ramirez, Angelica Zambrano, Robert Hennis, Nathan A. Holland, Rajkumar Lakshmanaswamy, Jessica Ann Chacon · 2023 · Vaccines
  37. Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy
    Henoch Sangjoon Hong, Sven Dominik Koch, Birgit Scheel, Ulrike Gnad-Vogt, Andreas Schröder, Karl‐Josef Kallen, Volker Wiegand, Linus Backert, Oliver Kohlbacher, Ingmar Hoerr et al. · 2016 · OncoImmunology
  38. Development of mRNA vaccines and their prophylactic and therapeutic applications
    Kyuri Lee, Minjeong Kim, Yunmi Seo, Hyukjin Lee · 2018 · Nano Research
  39. Nonviral targeted mRNA delivery: principles, progresses, and challenges
    Xi He, Guohong Li, Letao Huang, Haixing Shi, Sha Zhong, Siyu Zhao, Xiangyu Jiao, Jinxiu Xin, Xiaoling Yin, Shengbin Liu et al. · 2025 · MedComm
  40. mRNA-based therapies: Preclinical and clinical applications
    Musga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, Sarah E. Knudsen, Farrukh Vohidov, Andoni Garitano-Trojaola · 2022 · International review of cytology
  41. Proximity Ligation Assays for In Situ Detection of Innate Immune Activation: Focus on In Vitro-Transcribed mRNA
    Emmeline L. Blanchard, Kristin H. Loomis, Sushma M. Bhosle, Daryll A. Vanover, Patrick Baumhof, Bruno Pitard, Chiara Zurla, Philip J. Santangelo · 2018 · Molecular Therapy — Nucleic Acids
  42. Comprehensive Analysis of the Safety Profile of a Single-Stranded RNA Nano-Structure Adjuvant
    Hyeong-Jun Park, Hae Li Ko, Dong‐Hoon Won, Da‐Bin Hwang, Yoo‐Sub Shin, Hye‐Won Kwak, Hye‐Jung Kim, Jun-Won Yun, Jae‐Hwan Nam · 2019 · Pharmaceutics
  43. mRNA vaccine development and applications: A special focus on tumors (Review)
    Bangjie Chen, Yipin Yang, Xinyi Wang, Wenzhi Yang, You Lu, Daoyue Wang, Enba Zhuo, Yanchao Tang, Junhong Su, Guozheng Tang et al. · 2024 · International Journal of Oncology
  44. Optimal delivery strategies for nanoparticle-mediated mRNA delivery
    Xiaoyan Li, Xiaocui Guo, Mingdi Hu, Rong Cai, Chunying Chen · 2023 · Journal of Materials Chemistry B
  45. Making the Next Generation of Therapeutics: mRNA Meets Synthetic Biology
    Ahmet Hınçer, Recep Erdem Ahan, Ebru Aras, Urartu Özgür Şafak Şeker · 2023 · ACS Synthetic Biology
  46. Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
    Elias Joseph Sayour, Luis A Sanchez-Perez, Catherine Flores, Duane A. Mitchell · 2015 · Journal for ImmunoTherapy of Cancer
  47. Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
    Wubetu Yihunie Belay, Getinet Nibret, Yibeltal Aschale · 2023 · Clinical Pharmacology Advances and Applications
  48. A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses
    Pengcheng Yu, Mo Dan, Ying He, Shengli Meng, Han-Yu Yang, Xiaoye Su, Yajuan Wang, Lu Lv, Yufei Sun, Xiaoyan Tao et al. · 2023 · Microbial Pathogenesis
  49. Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations
    Emily Konopka, Arden O. Edgerton, Michele A. Kutzler · 2025 · Frontiers in Immunology
  50. Advanced nanoscale delivery systems for mRNA-based vaccines
    Maha Mobasher, Rais Ahmad Ansari, Ana Maria Castejon, Jaleh Barar, Yadollah Omidi · 2024 · Biochimica et Biophysica Acta (BBA) - General Subjects
  51. A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice
    Pascal Brandys, Xavier Montagutelli, Irena Merenkova, G. Tuba Barut, Volker Thiel, Nicholas J. Schork, Bettina Salome Trüeb, Laurine Conquet, Aihua Deng, Aleksandar Antanasijevic et al. · 2022 · Frontiers in Immunology
  52. DNA-protamine condensates under low salt conditions: molecular dynamics simulation with a simple coarse-grained model focusing on electrostatic interactions
    Yun Hee Jang, Éric Raspaud, Yves Lansac · 2023 · Nanoscale Advances
  53. Research progress of mRNA vaccines for infectious diseases
    Zhen Zhang, Jingli Du, Danyang Zhang, Rui Han, Xueqiong Wu, Yan Liang · 2025 · European journal of medical research
  54. Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data
    Begoña Alburquerque-González, María Dolores López-Abellán, Ginés Luengo‐Gil, Silvia Montoro‐García, Pablo Conesa‐Zamora · 2022 · Methods in molecular biology
  55. Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
    Ziqi Cheng, Junfeng Ma, Chenyan Zhao · 2024 · Vaccines
  56. Nonlysosomal Route of mRNA Delivery and Combining with Epigenetic Regulation Optimized Antitumor Immunoprophylactic Efficacy
    Yu Liu, Xü Liu, Jiaxin Huang, Yingying Shi, Zhenyu Luo, Junlei Zhang, Xuemeng Guo, Mengshi Jiang, Xiang Li, Hang Yin et al. · 2022 · Advanced Healthcare Materials
  57. A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2
    Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, S Ganesan, Mukesh Doble, Sathiah Thennarasu · 2021 · RSC Advances
  58. Expanding horizons of cancer immunotherapy: hopes and hurdles
    Priyanka Vijay Sonar, Anuj Kumar Singh, Sravan Mandadi, Nilesh Kumar Sharma · 2025 · Frontiers in Oncology
  59. mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious Diseases
    Saeideh Khorshid Sokhangouy, Matine Behzadi, Shokuh Rezaei, Mahsa Farjami, Milad Haghshenas, Yahya Sefidbakht, Sina Mozaffari‐Jovin · 2025 · Biotechnology Journal
  60. mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications
    Radhika Joshi, Swapnil Sharma, Devesh U. Kapoor, Bhupendra G. Prajapati, Kampanart Huanbutta, Pornsak Sriamornsak · 2026 · Molecular Pharmaceutics
  61. Macromolecular Systems for Vaccine Delivery
    Gabriela Mužíková, Richard Laga · 2016 · Physiological Research
  62. Towards mRNA therapeutics 2.0
    Kenneth R. Chien, Kylie S. Foo, Nevin Witman · 2026 · Nature Reviews Drug Discovery
  63. Lessons learned from COVID-19 pandemic: Vaccine platform is a key player
    Samira Hossaini Alhashemi, Fatemeh Ahmadi, Ali Dehshahri · 2022 · Process Biochemistry
  64. Current status of vaccine immunotherapy for gastrointestinal cancers
    Nobuaki Suzuki, Yoshitaro Shindo, Masao Nakajima, Ryouichi Tsunedomi, Hiroaki Nagano · 2023 · Surgery Today
  65. Vaccine approaches to treat urothelial cancer
    Giulia Claire Giudice, Guru Sonpavde · 2024 · Human Vaccines & Immunotherapeutics
  66. mRNA as a Therapeutics: Understanding mRNA Vaccines
    Ferdi Oğuz, Harika Atmaca · 2021 · Advanced Pharmaceutical Bulletin
  67. From Basic Immunology to New Therapies for Cancer Patients
    Hans‐Georg Rammensee · 2014 · Springer eBooks
  68. Bladder cancer immunotherapy parallel advances in BCG optimization and next-generation vaccine platforms
    Fengshuo Li, Dawei Wang, Yuan Gao, Yuanshan Cui · 2025 · Frontiers in Immunology
  69. mRNA and Peptide Vaccines in Melanoma—Current Landscape and Future Direction
    Jiaxing Jason Qin, Yang Wang, Shahneen Sandhu · 2026 · Cells
  70. Unlocking Immunity: Innovative prostate cancer vaccine strategies
    Qiannan Gu, Anning Qi, Ne Wang, Zhenxian Zhou, Xiaohui. Zhou · 2024 · International Immunopharmacology
  71. Future prospects in mRNA vaccine development
    Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, Tukayi Kudanga · 2023 · Biomedical Materials
  72. Current status and future trends of vaccine development against viral infection and disease
    Hongpeng Wang, Zhi-Gang Wang, Shulin Liu · 2021 · New Journal of Chemistry
  73. Advances in mRNA vaccines for viral diseases
    Yukai Huang, Xuerui Zhu, Xiao Guo, Yuancheng Zhou, Dongying Liu, Jingrui Mao, Yongai Xiong, Youcai Deng, Xinghong Gao · 2023 · Journal of Medical Virology
  74. A mRNA vaccine encoding for a 60-mer Nipah virus G glycoprotein nanoparticle elicits a robust neutralizing antibodies response against the Nipah virus
    Pascal Brandys, César G. Albariño, Shilpi Jain, Irena Merenkova, Nicholas J. Schork, Aihua Deng, Martine Valière, Jens Herold · 2025 · Vaccine
  75. Vaccine through Centuries. Major Cornerstone of Global Health
    Rehan Haider · 2023 · Asian Journal of Pharmacy and Technology
  76. Advances, opportunities and challenges in developing therapeutic cancer vaccines
    Zhihui Duan, Dandan Yang, Ping Yuan, Xiaoming Dai, Guodong Chen, Daichao Wu · 2023 · Critical Reviews in Oncology/Hematology
  77. Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization
    Awais Ali · 2025 · Current Medical Science
  78. In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular Delivery
    Αndroulla N. Miliotou, Ioannis S. Pappas, Ioannis S. Vizirianakis, Lefkothea C. Papadopoulou · 2022 · RNA technologies
  79. Single-molecule measurements of double-stranded DNA condensation
    Helena Gien, Ioulia F. Rouzina, Michael Morse, Micah J. McCauley, Mark C. Williams · 2025 · Biophysical Journal
  80. mRNA vaccines in gastric cancer: How close are we?
    José Darío Portillo‐Miño, David Bettin-Gonzalez, Franco Andrés Montenegro Coral · 2024 · Vacunas (English Edition)
  81. Reprogramming Glutamine Metabolism of Dendritic Cells Boosts Lymph Nodes Migration and Tumor Immunotherapy
    Yi Pan, Lulu Jin, Yang Huang, Danfeng Jian, Курлович Иван Васильевич, Maksim Beluga, A.S. STALYBKA, Xiaozhou Mou, Yang Zhu, Zhengwei Mao et al. · 2025 · Advanced Functional Materials
  82. pH-Responsive Conformational-Switching Cationic Fusion Protein for Promoted Plasmid DNA Delivery and Transfection
    Jun Wu, Tiantian Tan, Jinghua Chen, Yan Zhang · 2025 · Biomacromolecules
  83. Design and preparation of a multifunctional curcumin containing Pickering emulsion using cross-linked composite colloidal particles of Chitosan-Protamine as stabilizer
    Anand A. Sable, Minati Nayak, Sanjeev Kumar, Amit Kunwar, Atanu Barik · 2026 · Colloids and Surfaces A Physicochemical and Engineering Aspects
  84. mRNA vaccines in cancer immunotherapy: current progress and perspectives in solid tumors and hematologic malignancies
    N Qiao, Jingxian Chen, Yan Liu, Z. Jeffrey Chen, S. -J. Chen · 2026 · MedScience
  85. Recent Updates on mRNA Vaccines
    Emily Sydow, Abu Salim Mustafa, Asma Hanif, Javed H. Tunio, Shumaila Nida Muhammad Hanif · 2022 · Vaccines
  86. Preparation of Messenger RNA-Loaded Nanomedicine Applied on Tissue Engineering and Regenerative Medicine
    Hsi‐Kai Tsou, Cheng-Chung Chang, Tomoji Maeda, Chin‐Yu Lin · 2022 · RNA technologies
  87. mRNA vaccines in gastric cancer: How close are we?
    José Darío Portillo‐Miño, David Bettin-Gonzalez, Franco Andrés Montenegro Coral · 2023 · Vacunas
  88. [Illuminating the shadows - perspectives on mRNA vaccine adverse events - mechanisms, risks and management]: A review
    Haobo Kang, Yubo Sun, Zhenchi Fang, Weijie Ding, Tianyuan Bai, Kun Yang, Dongbo Jiang · 2025 · International Journal of Biological Macromolecules
  89. Mapping a New Blueprint of Multimodal Immunotherapy Against Prostate Cancer: Breakthroughs, Barriers, and Bold Frontiers
    Yiting Wang, Fei Cao, Mengjun Huang, Qiliang Teng, Yupeng Guan, Jun Pang · 2025 · The FASEB Journal
  90. RNA-based vaccines against SARS-CoV-2
    Sergio Rosales‐Mendoza, Alejandra Wong-Arce, Lourdes Betancourt-Mendiola · 2021 · Elsevier eBooks
  91. Innovation in the 21st century: following the footsteps of Katalin Karikó
    Csaba Deák, Norbert Pardi, Ádám Miklósi · 2023 · Biologia Futura
  92. Sequence-Optimized mRNA Vaccines Against Infectious Disease
    Susanne Rauch, Johannes Lutz, Janine Mühe, Aleksandra Kowalczyk, Thomas Schlake, Regina Heidenreich · 2024 · Methods in molecular biology
  93. Harnessing mRNA vaccines for viral diseases: bottleneck and breakthrough
    Vijay Kumar Mishra, Abhigyan Ranjan, Yachana Mishra · 2025 · Exploration of Immunology
  94. mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules
    Mahsa Hosseini Kakroudi, Ali Rezvanimehr, Kosar Zolfaghari, Ghazaleh Baghaei-Shiva, Hesan Abbasi, Mohammad Pourashory, Niloufar Yazdanpanah, Kiarash Saleki, Nima Rezaei · 2026 · Discover Oncology
  95. DNA vaccines onward and upward! 20 years and counting! Highlights of the DNA Vaccines 2012 Meeting
    Kenneth E. Ugen, David B. Weiner · 2013 · Human Vaccines & Immunotherapeutics
  96. RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug
    Natalia Teresa Jarzębska, Marina Tusup, Julia Frei, Tobias Weiß, Tim Holzinger, Mark Mellett, Mustafa Diken, Simon Bredl, Michael Weller, Roberto F. Speck et al. · 2022 · OncoImmunology
  97. Rational design of an EDIII mRNA vaccine candidate against Zika virus
    Ying Tian, Mei Wu, Kai Li, Chao Hui ZHOU, Rongrong Zhang, Hangyu Zhou, Qing Ye, Cheng‐Feng Qin, Shenghai Huang, Xiao-Feng Li · 2023 · Chinese Science Bulletin (Chinese Version)
  98. RNAs in the diagnosis and treatment of major diseases
    Di Huang, Tianying Zhang, Xiaohua Jiang, Jiang Li, Zhangcai Yan, Ruijuan Sun, Shicheng Su, Wei Hong · 2024 · Chinese Science Bulletin (Chinese Version)
  99. In-vivo Delivery of mRNA-Based Vaccines and Administration Routes
    Ramazan Gümral · 2021 · Journal of Molecular Virology and Immunology
  100. A mRNA vaccine encoding for a RBD 60-mer nanoparticle elicits neutralizing antibodies and protective immunity against the SARS-CoV-2 delta variant in transgenic K18-hACE2 mice
    Pascal Brandys, Xavier Montagutelli, Irena Merenkova, G. Tuba Barut, Volker Thiel, Nicholas J. Schork, Bettina Salome Trüeb, Laurine Conquet, Aihua Deng, Aleksandar Antanasijevic et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)